platoseedplatoseed
Next-generation biocides for sustainable agriculture at scale
ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides. Our mission is to transform agriculture through sustainable biological crop protection that increases yields while safeguarding the environment, farmers, and consumers.
ACX Therapeutics develops next-generation biocides for sustainable agriculture, focusing on precision-engineered actives to reduce reliance on broad-spectrum chemicals while supporting soil health and resistance management.
ACX builds precision-engineered biocides designed to target plant diseases at the source, offering eco-friendly alternatives to traditional chemical pesticides. The platform emphasizes sustainable agriculture at scale, aiming to disrupt disease while preserving soil health and improving resistance management, enabling precise application and disease control within agricultural systems.
Who it’s for: Agricultural producers and farmers seeking sustainable disease control; agritech and horticulture operations; organizations aiming to reduce chemical pesticide usage while maintaining crop health.
funding/traction mentions are not explicitly stated; company highlights platform and mission, suggesting early-stage or growth-focused biotech/agritech startup
Emmanouela is the Co-Founder & CEO of ACX and PhD in Biochemistry and Biophysics from the University of Cambridge. Previously, she held several research positions working in immunology, cancer, malaria vaccine development and viral drug discovery (in institutes like Barts Cancer Institute CRUK, Cambridge University, King’s College London, Institute Curie France and Imperial College London).
Melina is the Co-founder & CTO of ACX and PhD in Computer Science from King's College London. Previously, she held several research positions spanning digital health, robotics, technology-enable interventions, HCAI and NLP (in institutes like Cambridge University, King’s College London, National Health Service (NHS) in England and Francis Crick Institute).
ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides.
ACX develops a new therapeutic approach with applications in animal farming and agriculture, discovering a common biological pathway to target pathogens. They announce in vitro validation of their therapeutic, focus on animal health and crop production, and describe a drug delivery system that aims to minimize toxicity while enabling targeted, spatiotemporal release.
Formerly “AcX Therapeutics” · why startups rename →
Genetically engineering plants for disease resistance.
AI-driven HVAC control system for improved energy performance
